205 related articles for article (PubMed ID: 37753167)
21. Clinical benefits of oral anticoagulants in atrial fibrillation patients with dementia: a systematic review and meta-analysis.
Wang D; Xu X; Han X; Xie J; Zhou H; Peng W; Pan G
Front Cardiovasc Med; 2023; 10():1265331. PubMed ID: 37731522
[TBL] [Abstract][Full Text] [Related]
22. Atrial fibrillation is associated with sudden cardiac death: a systematic review and meta-analysis.
Rattanawong P; Upala S; Riangwiwat T; Jaruvongvanich V; Sanguankeo A; Vutthikraivit W; Chung EH
J Interv Card Electrophysiol; 2018 Mar; 51(2):91-104. PubMed ID: 29332241
[TBL] [Abstract][Full Text] [Related]
23. Systematic screening for the detection of atrial fibrillation.
Moran PS; Teljeur C; Ryan M; Smith SM
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD009586. PubMed ID: 27258214
[TBL] [Abstract][Full Text] [Related]
24. Blood lipid profiles and risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies.
Guan B; Li X; Xue W; Tse G; Waleed KB; Liu Y; Zheng M; Wu S; Xia Y; Ding Y
J Clin Lipidol; 2020; 14(1):133-142.e3. PubMed ID: 31926850
[TBL] [Abstract][Full Text] [Related]
25. Glycemic variability and the risk of atrial fibrillation: a meta-analysis.
Li W; Wang Y; Zhong G
Front Endocrinol (Lausanne); 2023; 14():1126581. PubMed ID: 37274320
[TBL] [Abstract][Full Text] [Related]
26. Effect of Long-Term Marine ɷ-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.
Gencer B; Djousse L; Al-Ramady OT; Cook NR; Manson JE; Albert CM
Circulation; 2021 Dec; 144(25):1981-1990. PubMed ID: 34612056
[TBL] [Abstract][Full Text] [Related]
27. Left atrial dimension and cardiovascular outcomes in patients with and without atrial fibrillation: a systematic review and meta-analysis.
Froehlich L; Meyre P; Aeschbacher S; Blum S; Djokic D; Kuehne M; Osswald S; Kaufmann BA; Conen D
Heart; 2019 Dec; 105(24):1884-1891. PubMed ID: 31422362
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of atrial fibrillation in hypertrophic cardiomyopathy: a systematic review.
Alphonse P; Virk S; Collins J; Campbell T; Thomas SP; Semsarian C; Kumar S
Clin Res Cardiol; 2021 Apr; 110(4):544-554. PubMed ID: 32880676
[TBL] [Abstract][Full Text] [Related]
29. Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation.
Duarte R; Stainthorpe A; Greenhalgh J; Richardson M; Nevitt S; Mahon J; Kotas E; Boland A; Thom H; Marshall T; Hall M; Takwoingi Y
Health Technol Assess; 2020 Jan; 24(3):1-164. PubMed ID: 31933471
[TBL] [Abstract][Full Text] [Related]
30. Effect of Digoxin Therapy on Mortality in Patients With Atrial Fibrillation: An Updated Meta-Analysis.
Wang X; Luo Y; Xu D; Zhao K
Front Cardiovasc Med; 2021; 8():731135. PubMed ID: 34660731
[No Abstract] [Full Text] [Related]
31. Meta-analysis of nonsteroidal anti-inflammatory drug use and risk of atrial fibrillation.
Liu G; Yan YP; Zheng XX; Xu YL; Lu J; Hui RT; Huang XH
Am J Cardiol; 2014 Nov; 114(10):1523-9. PubMed ID: 25260945
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for new-onset atrial fibrillation in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Huang Q; Xiong H; Shuai T; Zhang M; Zhang C; Wang Y; Zhu L; Lu J; Liu J
PeerJ; 2020; 8():e10376. PubMed ID: 33344074
[TBL] [Abstract][Full Text] [Related]
33. Association of type 1 diabetes mellitus and risk of atrial fibrillation: Systematic review and meta-analysis.
Guo S; Huang Y; Liu X; Ma J; Zhu W
Diabetes Res Clin Pract; 2023 May; 199():110629. PubMed ID: 36948422
[TBL] [Abstract][Full Text] [Related]
34. Nonalcoholic fatty liver disease is associated with increased risk of atrial fibrillation.
Cai X; Zheng S; Liu Y; Zhang Y; Lu J; Huang Y
Liver Int; 2020 Jul; 40(7):1594-1600. PubMed ID: 32279432
[TBL] [Abstract][Full Text] [Related]
35. Associations between adipokines and atrial fibrillation: A systematic review and meta-analysis.
Agbaedeng TA; Zacharia AL; Iroga PE; Rathnasekara VM; Munawar DA; Bursill C; Noubiap JJ
Nutr Metab Cardiovasc Dis; 2022 Apr; 32(4):853-862. PubMed ID: 35227548
[TBL] [Abstract][Full Text] [Related]
36. Impact of preexisting diabetes mellitus on cardiovascular and all-cause mortality in patients with atrial fibrillation: A meta-analysis.
Xu J; Sun Y; Gong D; Fan Y
Front Endocrinol (Lausanne); 2022; 13():921159. PubMed ID: 35979438
[TBL] [Abstract][Full Text] [Related]
37. Effect of digoxin on all-cause and cardiovascular mortality in patients with atrial fibrillation with and without heart failure: an umbrella review of systematic reviews and 12 meta-analyses.
Gazzaniga G; Menichelli D; Scaglione F; Farcomeni A; Pani A; Pastori D
Eur J Clin Pharmacol; 2023 Apr; 79(4):473-483. PubMed ID: 36872367
[TBL] [Abstract][Full Text] [Related]
38. Systemic lupus erythematosus increases risk of incident atrial fibrillation: A systematic review and meta-analysis.
Chen Y; Fu L; Pu S; Xue Y
Int J Rheum Dis; 2022 Oct; 25(10):1097-1106. PubMed ID: 35906745
[TBL] [Abstract][Full Text] [Related]
39. Association of diabetes with atrial fibrillation types: a systematic review and meta-analysis.
Alijla F; Buttia C; Reichlin T; Razvi S; Minder B; Wilhelm M; Muka T; Franco OH; Bano A
Cardiovasc Diabetol; 2021 Dec; 20(1):230. PubMed ID: 34876114
[TBL] [Abstract][Full Text] [Related]
40. Modifiable Risk Factors for Incident Heart Failure in Atrial Fibrillation.
Chatterjee NA; Chae CU; Kim E; Moorthy MV; Conen D; Sandhu RK; Cook NR; Lee IM; Albert CM
JACC Heart Fail; 2017 Aug; 5(8):552-560. PubMed ID: 28624486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
